ARF6 and breast cancer: We have shown previously that the GEP100-Arf6-AMAP1-cortactin pathway is used for invasion and metastasis of many breast cancer cells; and in this paper, we show that this pathway is also used in angiogenesis, including breast cancer-induced angiogenesis and choroidal neovascularization.